XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E903. A total of 3 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $574,740 | -19.1% | 309,000 | +13.9% | 0.00% | 0.0% |
| Q2 2023 | $710,806 | +244.5% | 271,300 | +114.3% | 0.00% | +100.0% |
| Q1 2023 | $206,358 | -78.0% | 126,600 | -82.1% | 0.00% | -50.0% |
| Q4 2022 | $938,182 | -20.0% | 705,400 | -6.1% | 0.00% | 0.0% |
| Q3 2022 | $1,172,000 | -3.8% | 751,000 | -5.1% | 0.00% | 0.0% |
| Q2 2022 | $1,218,000 | -35.1% | 791,000 | +8.0% | 0.00% | 0.0% |
| Q1 2022 | $1,876,000 | -40.1% | 732,700 | -31.4% | 0.00% | -33.3% |
| Q4 2021 | $3,130,000 | – | 1,068,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 126,600 | $206,358 | 0.00% |
| SIMPLEX TRADING, LLC | 92,000 | $149 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |